[TRANSITORY INSULIN RESISTANCE IN EMACIATED DIABETICS]. 1963

J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D004614 Emaciation Clinical manifestation of excessive LEANNESS usually caused by disease or a lack of nutrition (MALNUTRITION). Emaciations
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D049528 Insulin, Long-Acting Insulin formulations that contain substances that retard absorption thus extending the time period of action. Insulin, Semilente,Long-Acting Insulin,Insulin, Long Acting,Long Acting Insulin,Semilente Insulin

Related Publications

J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
January 1952, Deutsches Archiv fur klinische Medizin,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
April 1984, Experimental and clinical endocrinology,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
March 1994, Casopis lekaru ceskych,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
February 1977, Annales de medecine interne,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
January 1991, Vnitrni lekarstvi,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
September 2002, Saudi medical journal,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
February 1995, Vnitrni lekarstvi,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
July 1980, Endokrinologie,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
January 1954, Deutsches Archiv fur klinische Medizin,
J M FOLIGUET, and P VERT, and P ISSERT, and C FONTENAILL
July 1982, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!